Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection

Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...

詳細記述

書誌詳細
主要な著者: Downs, L, Patel, M, Ansari, M, McNaughton, A, Smith, D, Andersson, M, Barnes, E, Jeffery, K, Matthews, P
フォーマット: Conference item
出版事項: Elsevier 2018

類似資料